Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Research context
Financière de Tubize SA appears in PyInvesting’s Brussels Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Financière de Tubize SA is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.
From a valuation standpoint, the stock is 1468.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1000000.0.
Financière de Tubize SA's total revenue sank by 5.1% to $131M since the same quarter in the previous year.
Its net income has dropped by 5.0% to $130M since the same quarter in the previous year.
Finally, its free cash flow fell by 182.4% to $-761K since the same quarter in the previous year.
Based on the above factors, Financière de Tubize SA gets an overall score of 1/5.